Structure‐based drug design is achievable by exploiting the three‐dimensional information intrinsic in structural models of proteins that are involved in human disease. Many other tools (biochemistry, cellular and whole‐animal biology, organic synthesis, pharmaceutics, and computational analysis) must by tightly integrated to fulfill the promise of the structure‐based approach, and the use of this approach does not automatically guarantee success. However, the successes that have been achieved make it clear that structure‐based methods provide an efficient, effective, and elegant approach to medicinal chemistry. Examples are described in this chapter of the use of structure‐based methods in designing compounds that have entered human clinical trials and, in many cases, were launched as products. Some of the lessons that have been learned about best practices in the application of structure‐based methods are summarized.